Last updated on August 2018

S-Equol in Alzheimer's Disease 2 Trial

Brief description of study

By doing this study researchers hope to learn if S-equol, a compound that acts like estrogen in the body, causes an increase in mitochondrial activity. Researchers also hope to determine the safety and tolerability of a therapeutic dose of S-equol and whether or not it influences cognition.

Clinical Study Identifier: NCT03101085

Contact Investigators or Research Sites near you

Start Over

Annette Becker

Clinical and Translational Science Unit
Fairway, KS United States
  Connect »

Annette Becker

University of Kansas Medical Center
Kansas City, KS United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.